Markets of biodiversity and equity in trade: An illusion?

The Convention on Biological Diversity, adopted at the Rio de Janeiro Earth Summit of 1992, bore the objective of providing a legal and political framework for the conservation of biodiversity. In order to assess how these recommendations have been put into practice over the past 15 years, a team of scientists from the IRD and other research organizations has conducted a review aiming to analyse the strategies, practices and representations of the different participants in the trade of living resources.

Since the end of the 1980s, the idea has become predominant that the best way to ensure conservation of biodiversity was to create value for it in the framework of markets. The great upsurge in genetic engineering techniques at that time offered a glimpse of many possibilities for money-earning uses of natural substances by living-resource-based industries.

In this context, the Convention on Biological Diversity, a measure adopted in Rio de Janeiro in 1992, advocated the development of trade agreements between holders and users of genetic resources, foreseeing a fair and equitable sharing of benefits derived from such resources. Fifteen years after the signature of the Convention on Biological Diversity, a multidisciplinary team involving researchers from the IRD and other institutions conducted a review of the current situation. They highlighted the gap between the theories circulating around the Convention adopted in Brazil and the real situations prevailing in transactions, expectations and constraints which characterize the relations being established between the different parties involved: local communities, States of the South, industrial companies.

Over recent years, strong media coverage of “pillage” of local resources, food plants or products of traditional pharmacopoeias, on which patents had been taken out, appeared as signs of an active biopiracy. Some States of the South, supported by the non governmental organizations (NGOs), have therefore seen looming the risk of watching powerless an unbridled exploitation of indigenous people’s knowledge and resources, with insufficient means to stem the flow. Others considered that if regulated and reasoned, the use of genetic resources could favour their conservation while being a source of revenue for local communities and the countries of the South, but also allow biotechnological innovations and generate transfer of technology.

The idea of a market, bringing face to face a supply of genetic resources by the South and a demand emanating from the North, attracted by promises of financial reward, held up the bright prospect of development of these transactions. The representations conveyed by the Convention on Biological Diversity turn out to be simplistic. Analysis of the demand in the agricultural sector and the pharmaceutical industry in terms of research and development put into perspective the needs of these different users of biodiversity and provided an updated description of them.

The issues at stake for the pharmaceutical firms concern rather more the control over property rights protecting the synthesis of new compounds than access to genetic resources. Moreover, pharmaceutical industry demand bears at least as much on microorganisms from soils or the deep sea floors, even on chemical products and substances stemming from nanobiotechnology, as on “unknown plants” of tropical forests. Similarly, the recourse to indigenous knowledge for producing innovations and, even more so, the possibility for the peoples who have them to benefit from them seem to have been greatly overestimated.

On the supply side, it turned out that people handle their human relations in accordance with their environment and not the genetic resources assimilated with such merchandise. In addition, they do not always have the capacities for negotiating on an equal footing with industry. Fair trading, labels or geographical indications can be used to promote products generating from particular indigenous savoir-faire, but these instruments do not directly concern biodiversity. As for patents coming from the industrial world, they are not adapted for protecting collective knowledge and heritage.

The gulf that separates the founding representations of the Convention on Biological Diversity from the real situations is particularly evident with the problem of biopiracy. Extensive media coverage of certain cases like ayahuasca, a beverage based on plants with hallucinogenic properties consumed traditionally by shamans of Amazonian Indian tribes, or maca, a plant from the pharmacopoeia of Peru reputed for its aphrodisiac virtues, gives the illusion that biodiversity relates to elements whose interpretation remains indisputable.

The term in fact encompasses many different notions: filing of patents on applications or properties of plants collected in local communitieswith or without consent, disclosure or use of traditional knowledge for commercial ends, filing of common names as trade names, agreements whose clauses or implementation are unsatisfactory and so on. This gives it a rather hazy status which makes it more difficult to establish public policies that might ensure the conservation of biodiversity.

Source: Institut de Recherche Pour le Développement

Related stories:

Experts say slowing aging is way to fight diseases in 21st century
A group of aging experts from the United States and the United Kingdom suggest that the best strategy for preventing and fighting a multitude of diseases is to focus on slowing the biological processes of aging. The analysis is published on BMJ.com.
Review article provides tools for the Rosaceae genomics community
A recent paper published in the journal Plant Physiology provides a comprehensive overview of the genomics tools and resources available for the rapidly growing Rosaceae scientific community. Rosaceae is an economically important group of plants that comprises more than 3,000 species, including strawberry, apple, peach and pear. Members of this plant family provide high-value nutritional foods and they are also the source of other desirable aesthetic and industrial products.
UN's climate change guru sees record oil price as a positive
The UN's top climate change official said Thursday that record oil prices, which have surged to 146 dollars a barrel, were positive for the environment.
Smoke-Free Policies Very Effective in Reducing Heart Disease
Research reviewed by an international team of experts called together by the International Agency for Research on Cancer (IARC) concluded that smoke-free policies are “extremely effective” in reducing the health hazards of smoking.
The 21st century tomato
When tomatoes ripen in our gardens, we watch them turn gradually from hard, green globules to brightly colored, aromatic, and tasty fruits. This familiar and seemingly commonplace transformation masks a seething mass of components interacting in a well-regulated albeit highly complex manner. For generations, agriculturalists and scientists have bred tomatoes for size, shape, texture, flavor, shelf-life, and nutrient composition, more or less, one trait at a time. With the advent of molecular biology, mutagenesis and genetic transformation could produce tomatoes that were more easily harvested or transported or turned into tomato paste. Frequently, however, optimizing for one trait led to deterioration in another. For example, improving flavor could have a negative effect on yield.
'Early bird' project really gets the worm
Scientists from the LSU Museum of Natural Science, or MNS, recently participated in a project joining together the most prominent ornithological research programs in the world. This study – the largest study of bird genetics ever completed – has not only shaken up the avian evolutionary tree, but completely redrawn it. The results of this massive research project, which relied heavily upon the LSU MNS' genetic resources collection, will be published in Science on June 27.
Thinking ahead: Bacteria anticipate coming changes in their environment
Microbes may be smarter than we think. A new study by Princeton University researchers shows for the first time that bacteria don't just react to changes in their surroundings -- they anticipate and prepare for them.
3 sequencing companies join 1000 Genomes Project
Leaders of the 1000 Genomes Project announced today that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: 454 Life Sciences, a Roche company, Branford, Conn.; Applied Biosystems, an Applera Corp. business, Foster City, Calif.; and Illumina Inc., San Diego.

News discussion:

General Science news